IBDEI16L ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,21118,1,1,0)
 ;;=1^239.6
 ;;^UTILITY(U,$J,358.3,21118,1,8,0)
 ;;=8^Brain Neoplasm NOS
 ;;^UTILITY(U,$J,358.3,21118,2)
 ;;=^16739
 ;;^UTILITY(U,$J,358.3,21119,0)
 ;;=239.7^^118^1267^6
 ;;^UTILITY(U,$J,358.3,21119,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,21119,1,1,0)
 ;;=1^239.7
 ;;^UTILITY(U,$J,358.3,21119,1,8,0)
 ;;=8^Endocrine/Nerv Neoplasm NOS
 ;;^UTILITY(U,$J,358.3,21119,2)
 ;;=^267785
 ;;^UTILITY(U,$J,358.3,21120,0)
 ;;=239.81^^118^1267^12
 ;;^UTILITY(U,$J,358.3,21120,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,21120,1,1,0)
 ;;=1^239.81
 ;;^UTILITY(U,$J,358.3,21120,1,8,0)
 ;;=8^Retina/Choroid Neoplasm NOS
 ;;^UTILITY(U,$J,358.3,21120,2)
 ;;=^338224
 ;;^UTILITY(U,$J,358.3,21121,0)
 ;;=239.89^^118^1267^7
 ;;^UTILITY(U,$J,358.3,21121,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,21121,1,1,0)
 ;;=1^239.89
 ;;^UTILITY(U,$J,358.3,21121,1,8,0)
 ;;=8^Neoplasm,Oth Spec Sites
 ;;^UTILITY(U,$J,358.3,21121,2)
 ;;=^338225
 ;;^UTILITY(U,$J,358.3,21122,0)
 ;;=239.9^^118^1267^8
 ;;^UTILITY(U,$J,358.3,21122,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,21122,1,1,0)
 ;;=1^239.9
 ;;^UTILITY(U,$J,358.3,21122,1,8,0)
 ;;=8^Neoplasm,Unspec Site 
 ;;^UTILITY(U,$J,358.3,21122,2)
 ;;=^82022
 ;;^UTILITY(U,$J,358.3,21123,0)
 ;;=288.9^^118^1267^15
 ;;^UTILITY(U,$J,358.3,21123,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,21123,1,1,0)
 ;;=1^288.9
 ;;^UTILITY(U,$J,358.3,21123,1,8,0)
 ;;=8^Unspec Dis of WBC
 ;;^UTILITY(U,$J,358.3,21123,2)
 ;;=^267993
 ;;^UTILITY(U,$J,358.3,21124,0)
 ;;=289.0^^118^1267^13
 ;;^UTILITY(U,$J,358.3,21124,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,21124,1,1,0)
 ;;=1^289.0
 ;;^UTILITY(U,$J,358.3,21124,1,8,0)
 ;;=8^Secondary Polycythemia
 ;;^UTILITY(U,$J,358.3,21124,2)
 ;;=^186856
 ;;^UTILITY(U,$J,358.3,21125,0)
 ;;=289.81^^118^1267^10
 ;;^UTILITY(U,$J,358.3,21125,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,21125,1,1,0)
 ;;=1^289.81
 ;;^UTILITY(U,$J,358.3,21125,1,8,0)
 ;;=8^Primary Hypercoagulable State
 ;;^UTILITY(U,$J,358.3,21125,2)
 ;;=^329886
 ;;^UTILITY(U,$J,358.3,21126,0)
 ;;=289.9^^118^1267^14
 ;;^UTILITY(U,$J,358.3,21126,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,21126,1,1,0)
 ;;=1^289.9
 ;;^UTILITY(U,$J,358.3,21126,1,8,0)
 ;;=8^Unspec Blood Disease
 ;;^UTILITY(U,$J,358.3,21126,2)
 ;;=^55344
 ;;^UTILITY(U,$J,358.3,21127,0)
 ;;=20550^^119^1268^29^^^^1
 ;;^UTILITY(U,$J,358.3,21127,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,21127,1,2,0)
 ;;=2^TENDON SHEATH/LIGAMENT/CYST
 ;;^UTILITY(U,$J,358.3,21127,1,3,0)
 ;;=3^20550
 ;;^UTILITY(U,$J,358.3,21128,0)
 ;;=20600^^119^1268^9^^^^1
 ;;^UTILITY(U,$J,358.3,21128,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,21128,1,2,0)
 ;;=2^DRAIN/INJ SM JT W/O US GUIDANCE
 ;;^UTILITY(U,$J,358.3,21128,1,3,0)
 ;;=3^20600
 ;;^UTILITY(U,$J,358.3,21129,0)
 ;;=20605^^119^1268^5^^^^1
 ;;^UTILITY(U,$J,358.3,21129,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,21129,1,2,0)
 ;;=2^DRAIN/INJ INT JT W/O US GUIDANCE
 ;;^UTILITY(U,$J,358.3,21129,1,3,0)
 ;;=3^20605
 ;;^UTILITY(U,$J,358.3,21130,0)
 ;;=20610^^119^1268^7^^^^1
 ;;^UTILITY(U,$J,358.3,21130,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,21130,1,2,0)
 ;;=2^DRAIN/INJ LG JT W/O US GUIDANCE
 ;;^UTILITY(U,$J,358.3,21130,1,3,0)
 ;;=3^20610
 ;;^UTILITY(U,$J,358.3,21131,0)
 ;;=26010^^119^1268^11^^^^1
 ;;^UTILITY(U,$J,358.3,21131,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,21131,1,2,0)
 ;;=2^DRAINAGE FINGER ABSCESS; SIM
 ;;^UTILITY(U,$J,358.3,21131,1,3,0)
 ;;=3^26010
 ;;^UTILITY(U,$J,358.3,21132,0)
 ;;=26020^^119^1268^3^^^^1
 ;;^UTILITY(U,$J,358.3,21132,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,21132,1,2,0)
 ;;=2^DRAIN TENDON SHEATH,HAND/FINGER
